Epithelial-mesenchymal transition in chronic hypersensitivity pneumonitis

Journal of Medical and Dental Sciences

Volumn 59, Issue 1, 2012, Pages 29-41

  Yasui, Makito ^a   Miyazaki, Yasunari ^a   Mitaka, Keiko ^a   Ishizuka, Masahiro ^a   Unoura, Koji ^a   Tamaoka, Meiyo ^a   Sumi, Yuki ^a   Inase, Naohiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Epithelial mesenchymal transition; Hypersensitivity pneumonitis; Murine model; Myofibroblast; Pulmonary fibrosis

Indexed keywords

ACTA2 PROTEIN, MOUSE; ACTIN; CADHERIN; COLLAGEN; DNA BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1; TTF1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BRONCHIOLE; C57BL MOUSE; CLASSIFICATION; DISEASE MODEL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; HUMAN; INBRED MOUSE STRAIN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; LUNG FIBROSIS; MACROPHAGE; MOUSE; MYOFIBROBLAST; PATHOLOGY; PHYSIOLOGY; TH1 CELL; TH2 CELL;

ACTINS; ANIMALS; BRONCHIOLES; CADHERINS; COLLAGEN; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LUNG DISEASES, INTERSTITIAL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MYOFIBROBLASTS; PULMONARY ALVEOLI; PULMONARY FIBROSIS; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84865083909     PISSN: 13428810     EISSN: 21859132     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ohtani Y, Saiki S, Sumi Y, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 200 2 AT/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax. 2005; 60: 665-671.
2. Churg A, Muller NL, Flint J, et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006;30:201-208
3. Miyazaki Y, Tateishi T, Akashi T, et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest. 2008; 134: 1265-1270.
4. Postlethwaite AE, Holness MA, Katai H, et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992; 90: 1479-1485.
5. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycinmouse model of lung fibrosis: downregulation of TFG-beta and procollagen I and III gene expression. Exp Lung Res. 1995; 21: 791-808.
6. Liu X, Kohyama T, Wang H, et al. Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am J Physiol. 2002; 282: L1049-L1056.
7. Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol. 1996; 167: 290-296
8. Saito A, Okazaki H, Sugawara I, et al. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol. 2003; 132: 168-176.
9. Hyde DM, Henderson TS, Giri SN, et al. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res. 1988; 14: 687-704.
10. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004; 4: 583-594.
11. Kishi M, Miyazaki Y, Jinta T, et al. Pathogenesis of cBFL in common with IPF? Correlation of IP-10/TARC ration with histological patterns. Thorax. 2008; 63: 810-816.
12. Barrera L, Mendoza F, Zuñiga J, et al. Functional diversity of T-cell subpopulation in subacute and chronic hypersensitivity pneumonitis. Am J Respir Cri Care Med. 2008; 177: 44-55.
13. Mitaka K, Miyazaki Y, Yasui M, et al. Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis. Int Arch Allergy Immunol. 2010; 154: 264-274.
14. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis. From innocent targets to serial killers. Proc Am Thorac Soc. 2006; 3: 364-372.
15. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003; 15: 740-746.
16. Iwano, M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002; 110: 341-350.
17. Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: Potential role in idiopathic pulmonary fibrosis. Am J Pathol. 2005; 166: 1321-1332.
18. Ohtani Y, Kojima K, Sumi Y, et al. Inhalation provocation tests in chronic bird fancier's lung. Chest. 2000; 118: 1382-1389.
19. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988; 41: 467-470.
20. Jinta T, Miyazaki Y, Kishi M, et al. The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic fibrosis. Am J Clin Pathol. 2010; 134: 613-620.
21. Kasai H, Allen JT, Mason RM, et al. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res. 2005; 6: 56.
22. Nawshad A, Lagamba D, Polad A, et al. Transforming growth factor - beta signaling during epithe lial -mesenchymal transition: implications for embryogenesis and tumor metastasis. Cells Tissues Organs. 2005; 179: 11-23.
23. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counter acts TGF - beta1 - induced epithelial - to -mesenchymal transition and reverses chronic renal injury. Nat Med. 2003; 9: 964-968.
24. Xia JL, Dai C, Michalopoulos GK, Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol. 2006; 168: 1500-1512.
25. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA. 2006; 103: 180-185.
26. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci. 2005; 118: 873-887.
27. Jakubzick C, Kunkel SL, Puri RK, et al. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol Res. 2004; 30: 339-349.
28. Wynn TA. Cellular and molecular mechanisms of fibrosis: J Pathol. 2008; 214: 199-210.
29. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998; 157: 1301-1315.
30. Harada T, Nabeshima K, Hamasaki M, et al. Epithelialmesenchymal transition in human lungs with usual interstitial pneumonia: Quantitative immunohistochemistry. Pathol Int. 2010; 60: 14-21.
31. Morali OG, Delmas V, Moore R, et al. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene. 2001; 20: 4942-4950.
32. Chilosi M, Poletti V, Zamò A, et al. Aberrant Wnt/betacatenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003; 162: 1495-1502.
33. Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: A role in aberrant angiogenesis. Am J Respir Crit Care Med. 2004; 170: 242-251.
34. Yamada M, Kuwano K, Maeyama T, et al. Dualimmunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem cell Biol. 2008; 129: 453-462.